From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases

Effective treatment of inflammatory diseases is often challenging owing to their heterogeneous pathophysiology. Understanding of the underlying disease mechanisms is improving and it is now clear that eosinophils play a complex pathophysiological role in a broad range of type 2 inflammatory diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavord, Ian D., Bel, Elisabeth H., Bourdin, Arnaud, Chan, Robert, Han, Joseph K., Keene, Oliver N., Liu, Mark C., Martin, Neil, Papi, Alberto, Roufosse, Florence, Steinfeld, Jonathan, Wechsler, Michael E., Yancey, Steven W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293125/
https://www.ncbi.nlm.nih.gov/pubmed/34402066
http://dx.doi.org/10.1111/all.15056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293125/
https://www.ncbi.nlm.nih.gov/pubmed/34402066
http://dx.doi.org/10.1111/all.15056

Ejemplares similares